(SPYL) SPDR SP500 USD Acc USD - Ratings and Ratios
Exchange: SW • Country: Switzerland • Currency: USD • Type: Etf • • US Large-Cap Blend Equity
SPYL: Stocks, Large, Cap, Equities, US, Companies
The SPDR S&P 500 UCITS ETF USD Acc USD (SW:SPYL) is an exchange-traded fund domiciled in Ireland, structured under the UCITS framework, which is widely recognized for its stringent regulatory standards and investor protections. This fund is designed to track the performance of the Morningstar US Large-Mid NR USD index, which focuses on large- and mid-capitalization companies in the U.S. equity market.
As part of the SPDR family of ETFs, this fund is managed by State Street Global Advisors, one of the largest and most established asset managers globally. The ETF is listed on the Swiss stock exchange, making it accessible to European investors while offering exposure to U.S. equities. It is categorized under the US Large-Cap Blend Equity segment, indicating its focus on a mix of growth and value stocks within the large-cap universe.
With an AUM of 8174.67M CHF, this ETF demonstrates significant scale, which often correlates with tighter bid-ask spreads and greater liquidity for investors. However, its important to note that certain key metrics such as P/E, P/B, and P/S are not readily available, which is not uncommon for ETFs that track broad market indices. Investors should focus on the underlying indexs characteristics and the funds tracking efficiency.
One critical consideration for investors is the funds currency exposure. Since it is traded in CHF but tracks U.S. dollar-denominated assets, currency fluctuations between the CHF and USD can impact returns. This makes it essential for investors to assess their own currency exposure and hedging needs. Additionally, the funds UCITS structure ensures compliance with European investment regulations, making it a viable option for fund managers and investors seeking regulatory certainty.
For fund managers and investors, this ETF serves as a core holding for U.S. large-cap equity exposure. Its broad diversification across the Morningstar index reduces single-stock risk while providing access to some of the most established companies in the U.S. market. The absence of leverage and derivatives aligns with a conservative investment approach, though it may not appeal to those seeking more nuanced or actively managed strategies.
Additional Sources for SPYL ETF
SPYL ETF Overview
Market Cap in USD | 7,955m |
Category | US Large-Cap Blend Equity |
TER | 0.03% |
IPO / Inception | 2023-10-31 |
SPYL ETF Ratings
Growth 5y | 54.5% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength | 0.36 |
Analysts | - |
Fair Price Momentum | 12.47 USD |
Fair Price DCF | - |
SPYL Dividends
No Dividends PaidSPYL Growth Ratios
Growth Correlation 3m | -47.8% |
Growth Correlation 12m | 86% |
Growth Correlation 5y | 94.6% |
CAGR 5y | 22.27% |
CAGR/Max DD 5y | 2.37 |
Sharpe Ratio 12m | 1.86 |
Alpha | 1.07 |
Beta | 0.921 |
Volatility | 14.57% |
Current Volume | 164.1k |
Average Volume 20d | 92.1k |
As of March 30, 2025, the stock is trading at USD 13.65 with a total of 164,133 shares traded.
Over the past week, the price has changed by -2.86%, over one month by -6.25%, over three months by -5.06% and over the past year by +8.85%.
Partly, yes. Based on ValueRay Analyses, SPDR SP500 USD Acc USD (SW:SPYL) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 54.53 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SPYL as of March 2025 is 12.47. This means that SPYL is currently overvalued and has a potential downside of -8.64%.
SPDR SP500 USD Acc USD has no consensus analysts rating.
According to ValueRays Forecast Model, SPYL SPDR SP500 USD Acc USD will be worth about 13.8 in March 2026. The stock is currently trading at 13.65. This means that the stock has a potential upside of +1.32%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 13.8 | 1.3% |